Cited by 59Cardiovascular Syncope and Autonomic DisordersPharmaceutical Practices and Patient OutcomesBalance, Gait, and Falls Prevention

Comparison of Incidence, Predictors, and the Impact of Co-Morbidity and Polypharmacy on the Risk of Recurrent Syncope in Patients <85 Versus ≥85 Years of Age

Ruwald, Martin Huth, Hansen, Morten Lock, Lamberts, Morten, Hansen, Carolina Malta, Numé, Anna-Karin, Vinther, Michael, Køber, Lars, Torp-Pedersen, Christian +2 more·2013·The American Journal of Cardiology

Abstract

Recurrent syncope is a major cause of hospitalizations and may be associated with cardiovascular co-morbidities. Despite this, prognostic factors and the clinical characteristics among patients are not well described. Therefore, we identified and analyzed data on all patients >50 years of age discharged after a first-time episode of syncope in the period 2001 to 2009 through nationwide administrative registries. We identified the clinical characteristics of 5,141 patients ≥85 years of age and 23,454 patients <85 years of age. Multivariate Cox models were used to assess prognostic factors associated with the end point of recurrent syncope according to age. We found that those with syncope and ≥85 years were more often women (65% vs 47%) and generally had a greater prevalence of noncardiovascular co-morbidities, whereas the prevalence of cardiovascular co-morbidities was more heterogeneously distributed across age groups. Overall, significant baseline predictors of recurrent syncope were aortic valve stenosis (hazard ratio [HR] 1.48, 95% confidence interval [CI] 1.31 to 1.68), impaired renal function (HR 1.34, 95% CI 1.15 to 1.58), atrioventricular or left bundle branch block (HR 1.32, 95% CI 1.16 to 1.51), male gender (HR 1.18, 95% CI 1.12 to 1.24), chronic obstructive pulmonary disorder (HR 1.10, 95% CI 1.02 to 1.19), heart failure (HR 1.10, 95% CI 1.02 to 1.21), atrial fibrillation (HR = 1.09, 95% CI 1.01 to 1.19), age per 5-year increment (HR 1.09, 95% CI 1.07 to 1.10), and orthostatic medications per increase (HR 1.06, 95% CI 1.03 to 1.09). Atrial fibrillation and impaired renal function both exhibited less prognostic importance for recurrent syncope in the elderly compared with younger population (p for interactions <0.01). In conclusion, predictive factors of recurrent syncope were closely associated with increased cardiovascular risk profile age and gender. The use of multiple orthostatic medications additively increased the risk of recurrences representing a need for strategies to reduce unnecessary polypharmacy.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2013.07.041

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The prescription of polypharmacy, cardiovascular medications, and psychotropic and dopaminergic drugs increases the risk of syncope and falls.

    “The prescription of polypharmacy, cardiovascular medications, and psychotropic (neuroleptics and antidepressants) and dopaminergic drugs also increases the risk of syncope and falls. 381-385”
  • Among older adults, risks of syncope are usually compounded by multiple morbidities and frailty, which add to age-related vulnerability to syncope.

    “Although some of the risk is attributable to the aspects of syncope described in this guideline, among older adults such risks are usually compounded by multiple morbidities and frailty, which add to age-related vulnerability to syncope (671,681,682), and by the physical injuries associated with falls, collisions, or trauma, which more commonly result from syncope in old age (670).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ruwald, M. H., Hansen, M. L., Lamberts, M., Hansen, C. M., Numé, A.-K., Vinther, M., Køber, L., Torp-Pedersen, C., Hansen, J., & Gislason, G. H.
Affiliations
  • Gentofte Hospital (DK)
  • Rigshospitalet (DK)
Corresponding author
Ruwald, Martin Huth
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2013-11
Volume
112
Issue
10
Pages
1610-1615
ISSN
0002-9149 (ISSN-L)
OpenAlex
W1967390646
Cited by
59
References
30
Citations by year
2026: 1 · 2023: 2 · 2022: 14 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 7
FWCI
5.25
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Lundbeckfonden (2012B018)
  • Helsefonden
  • Hjerteforeningen (R108-A104415)
  • Novo Nordisk Fonden
  • Else og Mogens Wedell Wedellsborgs Fond
  • Arvid Nilssons Fond
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
Keywords
recurrent syncope, syncope, oldest old, polypharmacy, comorbidities, aortic stenosis, renal dysfunction, atrial fibrillation, heart failure, bundle branch block, prognostic factors, cardiovascular comorbidity, age differences, hospitalization risk, older adults, chronic obstructive pulmonary disease, atrioventricular block
MeSH terms
Aged, Aged, 80 and over, Cardiovascular Agents, Denmark, Female, Humans, Male, Middle Aged, Registries, Risk Factors, Syncope, Comorbidity, Prevalence, Survival Rate, Proportional Hazards Models, Risk Assessment, Polypharmacy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review